US to lead Biocon Biologics’ drive towards $1 billion revenue
Biocon Biologics, arm of biopharmaceutical major Biocon, which posted strong revenue growth of 31 per cent for the December quarter of FY20, will continue to be the growth driver for the Bengaluru-…
